BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15771904)

  • 1. The effectiveness of high-resolution-comparative genomic hybridization in detecting the most common chromosomal abnormalities in pediatric myelodysplastic syndromes.
    Babicz M; Kowalczyk JR; Winnicka D; Gaworczyk A; Lejman M; Dmowski R; Kaczanowska K
    Cancer Genet Cytogenet; 2005 Apr; 158(1):49-54. PubMed ID: 15771904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of high-resolution comparative genomic hybridization (HR-CGH) in detection of chromosomal abnormalities in children with acute leukaemia.
    Vranova V; Mentzlova D; Oltova A; Linkova V; Zezulkova D; Filkova H; Mendelova D; Sterba J; Kuglik P
    Neoplasma; 2008; 55(1):23-30. PubMed ID: 18190236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of high-resolution comparative genomic hybridization (CGH) for detecting and characterizing constitutional chromosome abnormalities.
    Ness GO; Lybaek H; Houge G
    Am J Med Genet; 2002 Nov; 113(2):125-36. PubMed ID: 12407702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic and comparative genomic hybridization study of Indian myelodysplastic syndromes.
    Kawankar N; Jijina F; Ghosh K; Vundinti BR
    Cancer Epidemiol; 2011 Aug; 35(4):e1-5. PubMed ID: 21193364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular definition of chromosome arm 5q deletion end points and detection of hidden aberrations in patients with myelodysplastic syndromes and isolated del(5q) using oligonucleotide array CGH.
    Evers C; Beier M; Poelitz A; Hildebrandt B; Servan K; Drechsler M; Germing U; Royer HD; Royer-Pokora B
    Genes Chromosomes Cancer; 2007 Dec; 46(12):1119-28. PubMed ID: 17823930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of conventional cytogenetics, comparative genomic hybridisation and interphase fluorescence in situ hybridisation for the detection of genomic rearrangements in acute leukaemia.
    McGrattan P; Campbell S; Cuthbert R; Jones FG; McMullin MF; Humphreys M
    J Clin Pathol; 2008 Aug; 61(8):903-8. PubMed ID: 18474541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category.
    Bacher U; Schnittger S; Kern W; Weiss T; Haferlach T; Haferlach C
    Ann Hematol; 2009 Dec; 88(12):1207-13. PubMed ID: 19415278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence in situ hybridization improves the detection of 5q31 deletion in myelodysplastic syndromes without cytogenetic evidence of 5q-.
    Mallo M; Arenillas L; Espinet B; Salido M; Hernández JM; Lumbreras E; del Rey M; Arranz E; Ramiro S; Font P; González O; Renedo M; Cervera J; Such E; Sanz GF; Luño E; Sanzo C; González M; Calasanz MJ; Mayans J; García-Ballesteros C; Amigo V; Collado R; Oliver I; Carbonell F; Bureo E; Insunza A; Yañez L; Muruzabal MJ; Gómez-Beltrán E; Andreu R; León P; Gómez V; Sanz A; Casasola N; Moreno E; Alegre A; Martín ML; Pedro C; Serrano S; Florensa L; Solé F
    Haematologica; 2008 Jul; 93(7):1001-8. PubMed ID: 18591625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional cytogenetics and fluorescence in situ hybridization in persistent cytopenias and myelodysplastic syndromes in childhood.
    Touliatou V; Kolialexi A; Tsangaris GT; Moschovi M; Polychronopoulou S; Mavrou A
    Anticancer Res; 2004; 24(6):3945-9. PubMed ID: 15736436
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia.
    Casas S; Aventín A; Fuentes F; Vallespí T; Granada I; Carrió A; Angel Martínez-Climent J; Solé F; Teixidó M; Bernués M; Duarte J; Maria Hernández J; Brunet S; Dolors Coll M; Sierra J
    Cancer Genet Cytogenet; 2004 Aug; 153(1):16-25. PubMed ID: 15325089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal aberrations in congenital bone marrow failure disorders--an early indicator for leukemogenesis?
    Göhring G; Karow A; Steinemann D; Wilkens L; Lichter P; Zeidler C; Niemeyer C; Welte K; Schlegelberger B
    Ann Hematol; 2007 Oct; 86(10):733-9. PubMed ID: 17653548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of chromosomal imbalances in children with idiopathic mental retardation by array based comparative genomic hybridisation (array-CGH).
    Schoumans J; Ruivenkamp C; Holmberg E; Kyllerman M; Anderlid BM; Nordenskjöld M
    J Med Genet; 2005 Sep; 42(9):699-705. PubMed ID: 16141005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hidden chromosome 8 abnormalities detected by FISH in adult primary myelodysplastic syndromes.
    Panani AD; Pappa V
    In Vivo; 2005; 19(6):979-81. PubMed ID: 16277010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and numerical abnormalities resolved in one-step analysis: the most common chromosomal rearrangements detected by comparative genomic hybridization in childhood acute lymphoblastic leukemia.
    Kowalczyk JR; Babicz M; Gaworczyk A; Lejman M; Winnicka D; Styka B; Jaszczuk I
    Cancer Genet Cytogenet; 2010 Jul; 200(2):161-6. PubMed ID: 20620600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic screening at diagnosis of -5/del(5)(q31), -7, or chromosome 8 aneuploidy by interphase fluorescence in situ hybridization in 110 acute myelocytic leukemia and high-risk myelodysplastic syndrome patients: concordances and discrepancies with conventional cytogenetics.
    Beyer V; Castagné C; Mühlematter D; Parlier V; Gmür J; Hess U; Kovacsovics T; Meyer-Monard S; Tichelli A; Tobler A; Jacky E; Schanz U; Bargetzi M; Hagemeijer A; de Witte T; van Melle G; Jotterand M
    Cancer Genet Cytogenet; 2004 Jul; 152(1):29-41. PubMed ID: 15193439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic aberrations in myelodysplastic syndrome detected by comparative genomic hybridization and fluorescence in situ hybridization.
    Wilkens L; Burkhardt D; Tchinda J; Büsche G; Werner M; Nolte M; Ganser A; Georgii A
    Diagn Mol Pathol; 1999 Mar; 8(1):47-53. PubMed ID: 10408793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytogenetic aspects of adult primary myelodysplastic syndromes: clinical implications.
    Panani AD; Roussos C
    Cancer Lett; 2006 Apr; 235(2):177-90. PubMed ID: 15935553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do we need to do fluorescence in situ hybridization analysis in myelodysplastic syndromes as often as we do?
    Costa D; Valera S; Carrió A; Arias A; Muñoz C; Rozman M; Belkaid M; Coutinho R; Nomdedeu B; Campo E
    Leuk Res; 2010 Nov; 34(11):1437-41. PubMed ID: 20226525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of cytogenetics in myelodysplastic syndromes.
    Bernasconi P; Boni M; Cavigliano PM; Calatroni S; Giardini I; Rocca B; Zappatore R; Dambruoso I; Caresana M
    Ann N Y Acad Sci; 2006 Nov; 1089():395-410. PubMed ID: 17261783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative genomic hybridization in pediatric acute lymphoblastic leukemia.
    Rice M; Breen CJ; O'Meara A; Breatnach F; O'Marcaigh AS; Stallings RL
    Pediatr Hematol Oncol; 2000 Mar; 17(2):141-7. PubMed ID: 10734656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.